Home -> Law Blog Directory -> Patent Law Blogs -> Patent Docs

Patent Law

: Patent Docs

Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co. (Fed. Cir. 2009)

By Donald Zuhn, Kevin Noonan, Chris Singer, Sherri Oslick, and Jason Derry

By Andrew Williams -- On Friday, the Federal Circuit issued its decision in Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co., reversing the U.S. District Court for the District of Massachusetts's denial of Lilly's motion for JMOL in view of a jury verdict of infringement and validity of the asserted claims, and affirming the District Court's ruling that Lilly failed to establish the affirmative defense of inequitable conduct. The Ariad case involved the technology of gene regulation, and specifically the transcription factor NF-?B. NF-?B was first identified as playing a role in the expression of genes involved in the immune...

Full post as published by Patent Docs on April 06, 2009 (boomark / email).